Activation of SIRT1 and AMPK improves hepatic steatosis by enhancing carnitine palmitoyltransferase 1 (CPT-1) expression and promoting fatty acid β-oxidation for lipolysis [55,56]. This evidence concerns the gene SIRT1 and fatty liver disease.